Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Telemedicine May Adversely Impact Care Quality for HF Patients

Caitlin E. Cox

January 26, 2026

News Daily News

Year in Review: Reimbursement, Funding Cuts Mark Top Policy & Practice News

Yael L. Maxwell

December 26, 2025

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Todd Neale

May 09, 2025

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

Todd Neale

August 08, 2024

News Conference News ACC 2023

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

L.A. McKeown

March 06, 2023

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ACC 2022

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

L.A. McKeown

April 03, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

Michael O'Riordan

November 16, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

Advertisement

Telemedicine May Adversely Impact Care Quality for HF Patients

Year in Review: Reimbursement, Funding Cuts Mark Top Policy & Practice News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Acute HF Patients Live Longer When Seen by Specialists

ACC/AHA Update Performance, Quality Measures for HF Care

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

CV Care Around Noncardiac Surgery: New ESC Guidelines

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Canagliflozin Improves Quality of Life in HF Patients

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content